Intrinsic value of Israel Chemicals Shs - ICL

Previous Close

$5.32

  Intrinsic Value

$4.54

stock screener

  Rating & Target

hold

-15%

Previous close

$5.32

 
Intrinsic value

$4.54

 
Up/down potential

-15%

 
Rating

hold

We calculate the intrinsic value of ICL stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.60
  2.84
  3.06
  3.25
  3.43
  3.58
  3.72
  3.85
  3.97
  4.07
  4.16
  4.25
  4.32
  4.39
  4.45
  4.51
  4.56
  4.60
  4.64
  4.68
  4.71
  4.74
  4.76
  4.79
  4.81
  4.83
  4.84
  4.86
  4.87
  4.89
Revenue, $m
  5,700
  5,862
  6,042
  6,238
  6,452
  6,683
  6,932
  7,199
  7,484
  7,789
  8,113
  8,458
  8,823
  9,210
  9,620
  10,054
  10,512
  10,995
  11,506
  12,044
  12,611
  13,208
  13,837
  14,500
  15,197
  15,930
  16,702
  17,514
  18,368
  19,265
Variable operating expenses, $m
  1,007
  1,034
  1,063
  1,096
  1,131
  1,169
  1,210
  1,254
  1,301
  1,352
  1,338
  1,395
  1,455
  1,519
  1,587
  1,658
  1,734
  1,813
  1,898
  1,986
  2,080
  2,178
  2,282
  2,391
  2,506
  2,627
  2,755
  2,888
  3,029
  3,177
Fixed operating expenses, $m
  4,017
  4,106
  4,196
  4,289
  4,383
  4,479
  4,578
  4,679
  4,781
  4,887
  4,994
  5,104
  5,216
  5,331
  5,448
  5,568
  5,691
  5,816
  5,944
  6,075
  6,208
  6,345
  6,484
  6,627
  6,773
  6,922
  7,074
  7,230
  7,389
  7,551
Total operating expenses, $m
  5,024
  5,140
  5,259
  5,385
  5,514
  5,648
  5,788
  5,933
  6,082
  6,239
  6,332
  6,499
  6,671
  6,850
  7,035
  7,226
  7,425
  7,629
  7,842
  8,061
  8,288
  8,523
  8,766
  9,018
  9,279
  9,549
  9,829
  10,118
  10,418
  10,728
Operating income, $m
  676
  723
  782
  853
  938
  1,034
  1,143
  1,266
  1,401
  1,550
  1,781
  1,959
  2,152
  2,360
  2,585
  2,828
  3,088
  3,366
  3,664
  3,983
  4,323
  4,685
  5,071
  5,481
  5,918
  6,381
  6,874
  7,396
  7,950
  8,537
EBITDA, $m
  1,130
  1,187
  1,259
  1,344
  1,442
  1,555
  1,681
  1,821
  1,976
  2,146
  2,331
  2,533
  2,750
  2,985
  3,238
  3,510
  3,801
  4,112
  4,445
  4,800
  5,178
  5,581
  6,010
  6,465
  6,949
  7,462
  8,007
  8,584
  9,196
  9,844
Interest expense (income), $m
  0
  136
  143
  151
  160
  170
  181
  192
  205
  218
  233
  248
  264
  282
  300
  320
  340
  362
  385
  410
  435
  462
  491
  521
  553
  586
  621
  658
  697
  738
  781
Earnings before tax, $m
  540
  580
  631
  693
  767
  853
  951
  1,061
  1,183
  1,318
  1,533
  1,694
  1,870
  2,060
  2,266
  2,487
  2,725
  2,981
  3,255
  3,547
  3,860
  4,194
  4,550
  4,929
  5,332
  5,760
  6,216
  6,699
  7,212
  7,756
Tax expense, $m
  146
  156
  170
  187
  207
  230
  257
  286
  319
  356
  414
  457
  505
  556
  612
  672
  736
  805
  879
  958
  1,042
  1,132
  1,228
  1,331
  1,440
  1,555
  1,678
  1,809
  1,947
  2,094
Net income, $m
  394
  423
  460
  506
  560
  623
  694
  774
  863
  962
  1,119
  1,237
  1,365
  1,504
  1,654
  1,816
  1,989
  2,176
  2,376
  2,590
  2,818
  3,062
  3,321
  3,598
  3,892
  4,205
  4,537
  4,890
  5,265
  5,662

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  9,005
  9,261
  9,544
  9,854
  10,192
  10,557
  10,950
  11,372
  11,823
  12,305
  12,817
  13,361
  13,939
  14,551
  15,198
  15,883
  16,606
  17,370
  18,176
  19,026
  19,922
  20,866
  21,860
  22,906
  24,008
  25,167
  26,386
  27,668
  29,017
  30,435
Adjusted assets (=assets-cash), $m
  9,005
  9,261
  9,544
  9,854
  10,192
  10,557
  10,950
  11,372
  11,823
  12,305
  12,817
  13,361
  13,939
  14,551
  15,198
  15,883
  16,606
  17,370
  18,176
  19,026
  19,922
  20,866
  21,860
  22,906
  24,008
  25,167
  26,386
  27,668
  29,017
  30,435
Revenue / Adjusted assets
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
  0.633
Average production assets, $m
  5,068
  5,212
  5,371
  5,545
  5,735
  5,941
  6,162
  6,400
  6,653
  6,924
  7,212
  7,519
  7,844
  8,188
  8,553
  8,938
  9,345
  9,775
  10,228
  10,707
  11,211
  11,742
  12,301
  12,890
  13,510
  14,162
  14,848
  15,570
  16,329
  17,127
Working capital, $m
  1,208
  1,243
  1,281
  1,322
  1,368
  1,417
  1,469
  1,526
  1,587
  1,651
  1,720
  1,793
  1,871
  1,953
  2,040
  2,131
  2,229
  2,331
  2,439
  2,553
  2,673
  2,800
  2,933
  3,074
  3,222
  3,377
  3,541
  3,713
  3,894
  4,084
Total debt, $m
  2,554
  2,700
  2,861
  3,037
  3,229
  3,437
  3,661
  3,901
  4,157
  4,431
  4,723
  5,032
  5,361
  5,709
  6,078
  6,467
  6,879
  7,314
  7,772
  8,256
  8,766
  9,303
  9,868
  10,464
  11,090
  11,750
  12,444
  13,173
  13,941
  14,748
Total liabilities, $m
  5,124
  5,270
  5,431
  5,607
  5,799
  6,007
  6,231
  6,471
  6,727
  7,001
  7,293
  7,602
  7,931
  8,279
  8,648
  9,037
  9,449
  9,884
  10,342
  10,826
  11,336
  11,873
  12,438
  13,034
  13,660
  14,320
  15,014
  15,743
  16,511
  17,318
Total equity, $m
  3,881
  3,992
  4,114
  4,247
  4,393
  4,550
  4,720
  4,901
  5,096
  5,303
  5,524
  5,759
  6,008
  6,271
  6,550
  6,846
  7,157
  7,487
  7,834
  8,200
  8,586
  8,993
  9,422
  9,873
  10,347
  10,847
  11,372
  11,925
  12,506
  13,118
Total liabilities and equity, $m
  9,005
  9,262
  9,545
  9,854
  10,192
  10,557
  10,951
  11,372
  11,823
  12,304
  12,817
  13,361
  13,939
  14,550
  15,198
  15,883
  16,606
  17,371
  18,176
  19,026
  19,922
  20,866
  21,860
  22,907
  24,007
  25,167
  26,386
  27,668
  29,017
  30,436
Debt-to-equity ratio
  0.660
  0.680
  0.700
  0.720
  0.740
  0.760
  0.780
  0.800
  0.820
  0.840
  0.850
  0.870
  0.890
  0.910
  0.930
  0.940
  0.960
  0.980
  0.990
  1.010
  1.020
  1.030
  1.050
  1.060
  1.070
  1.080
  1.090
  1.100
  1.110
  1.120
Adjusted equity ratio
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431
  0.431

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  394
  423
  460
  506
  560
  623
  694
  774
  863
  962
  1,119
  1,237
  1,365
  1,504
  1,654
  1,816
  1,989
  2,176
  2,376
  2,590
  2,818
  3,062
  3,321
  3,598
  3,892
  4,205
  4,537
  4,890
  5,265
  5,662
Depreciation, amort., depletion, $m
  454
  465
  477
  490
  505
  521
  537
  556
  575
  596
  551
  574
  599
  625
  653
  682
  713
  746
  781
  817
  856
  896
  939
  984
  1,031
  1,081
  1,133
  1,189
  1,246
  1,307
Funds from operations, $m
  848
  888
  937
  997
  1,065
  1,144
  1,232
  1,330
  1,438
  1,558
  1,669
  1,811
  1,964
  2,129
  2,307
  2,498
  2,703
  2,922
  3,157
  3,407
  3,674
  3,958
  4,260
  4,582
  4,923
  5,286
  5,671
  6,079
  6,511
  6,969
Change in working capital, $m
  31
  34
  38
  42
  45
  49
  53
  57
  61
  65
  69
  73
  77
  82
  87
  92
  97
  103
  108
  114
  120
  127
  133
  140
  148
  156
  164
  172
  181
  190
Cash from operations, $m
  817
  854
  899
  955
  1,020
  1,095
  1,179
  1,273
  1,378
  1,493
  1,601
  1,738
  1,886
  2,047
  2,220
  2,406
  2,606
  2,820
  3,048
  3,293
  3,554
  3,831
  4,127
  4,441
  4,776
  5,131
  5,507
  5,907
  6,330
  6,779
Maintenance CAPEX, $m
  -377
  -387
  -398
  -410
  -423
  -438
  -454
  -470
  -489
  -508
  -529
  -551
  -574
  -599
  -625
  -653
  -682
  -713
  -746
  -781
  -817
  -856
  -896
  -939
  -984
  -1,031
  -1,081
  -1,133
  -1,189
  -1,246
New CAPEX, $m
  -127
  -144
  -159
  -175
  -190
  -205
  -221
  -237
  -254
  -271
  -288
  -306
  -325
  -344
  -364
  -385
  -407
  -430
  -454
  -478
  -504
  -531
  -559
  -589
  -620
  -652
  -686
  -722
  -759
  -798
Cash from investing activities, $m
  -504
  -531
  -557
  -585
  -613
  -643
  -675
  -707
  -743
  -779
  -817
  -857
  -899
  -943
  -989
  -1,038
  -1,089
  -1,143
  -1,200
  -1,259
  -1,321
  -1,387
  -1,455
  -1,528
  -1,604
  -1,683
  -1,767
  -1,855
  -1,948
  -2,044
Free cash flow, $m
  313
  323
  342
  370
  407
  451
  504
  566
  636
  714
  784
  881
  987
  1,104
  1,230
  1,368
  1,516
  1,676
  1,849
  2,034
  2,232
  2,444
  2,671
  2,913
  3,172
  3,447
  3,740
  4,052
  4,383
  4,735
Issuance/(repayment) of debt, $m
  129
  146
  161
  177
  192
  208
  224
  240
  257
  274
  291
  310
  329
  348
  369
  390
  412
  435
  459
  484
  510
  537
  566
  595
  627
  659
  694
  730
  767
  807
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  129
  146
  161
  177
  192
  208
  224
  240
  257
  274
  291
  310
  329
  348
  369
  390
  412
  435
  459
  484
  510
  537
  566
  595
  627
  659
  694
  730
  767
  807
Total cash flow (excl. dividends), $m
  442
  468
  503
  547
  599
  659
  728
  806
  892
  988
  1,075
  1,191
  1,316
  1,452
  1,599
  1,757
  1,928
  2,111
  2,307
  2,517
  2,742
  2,981
  3,237
  3,509
  3,799
  4,106
  4,434
  4,781
  5,150
  5,541
Retained Cash Flow (-), $m
  -100
  -110
  -122
  -134
  -145
  -157
  -169
  -182
  -194
  -207
  -221
  -235
  -249
  -264
  -279
  -295
  -312
  -329
  -347
  -366
  -386
  -407
  -428
  -451
  -475
  -500
  -526
  -553
  -581
  -611
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  342
  358
  381
  413
  453
  502
  558
  624
  698
  781
  855
  956
  1,067
  1,188
  1,320
  1,462
  1,616
  1,782
  1,960
  2,151
  2,356
  2,575
  2,808
  3,058
  3,324
  3,607
  3,908
  4,229
  4,569
  4,930
Discount rate, %
  6.10
  6.41
  6.73
  7.06
  7.41
  7.79
  8.17
  8.58
  9.01
  9.46
  9.94
  10.43
  10.95
  11.50
  12.08
  12.68
  13.32
  13.98
  14.68
  15.41
  16.19
  16.99
  17.84
  18.74
  19.67
  20.66
  21.69
  22.77
  23.91
  25.11
PV of cash for distribution, $m
  322
  316
  314
  314
  317
  320
  322
  323
  321
  316
  301
  291
  276
  259
  239
  216
  193
  169
  145
  122
  101
  81
  64
  50
  37
  27
  20
  14
  9
  6
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers. It also manufactures compound fertilizers in the Netherlands, Germany, and Belgium; liquid fertilizers and soluble fertilizers in Spain; slow release and controlled release fertilizers in the Netherlands and the United States; and phosphate-based food additives for livestock in Turkey and Israel. The Industrial Products segment produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, as well as bromine-based compounds; chlorine-based products in Israel and the United States; and flame retardants and phosphorus based products, as well as extracts salt, magnesia, and chlorine from Dead Sea brine. The Performance Products segment purchases clean phosphoric acid and manufactures thermal phosphoric acids, which are used to manufacture downstream products and phosphate salts that are used as a raw material for manufacturing, food additives, hygiene products and flame retardants, and fire extinguishment products. It also manufactures phosphorous derivatives based on phosphorous; specialty products based on aluminum acids; and other raw materials. The company sells its products through marketing companies, agents, and distributors. Israel Chemicals Ltd. was founded in 1968 and is headquartered in Tel Aviv, Israel.

FINANCIAL RATIOS  of  Israel Chemicals Shs (ICL)

Valuation Ratios
P/E Ratio 0
Price to Sales 0
Price to Book 0
Price to Tangible Book
Price to Cash Flow 0
Price to Free Cash Flow 0
Growth Rates
Sales Growth Rate -100%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate NaN%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio NaN
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 0%
Ret/ On Assets - 3 Yr. Avg. 0%
Return On Total Capital 0%
Ret/ On T. Cap. - 3 Yr. Avg. 0%
Return On Equity 0%
Return On Equity - 3 Yr. Avg. 0%
Asset Turnover 0
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 0%
EBITDA Margin - 3 Yr. Avg. 0%
Operating Margin 0%
Oper. Margin - 3 Yr. Avg. 0%
Pre-Tax Margin 0%
Pre-Tax Margin - 3 Yr. Avg. 0%
Net Profit Margin 0%
Net Profit Margin - 3 Yr. Avg. 0%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

ICL stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the ICL stock intrinsic value calculation we used $5556 million for the last fiscal year's total revenue generated by Israel Chemicals Shs. The default revenue input number comes from 0001 income statement of Israel Chemicals Shs. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our ICL stock valuation model: a) initial revenue growth rate of 2.6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.1%, whose default value for ICL is calculated based on our internal credit rating of Israel Chemicals Shs, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Israel Chemicals Shs.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of ICL stock the variable cost ratio is equal to 17.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3931 million in the base year in the intrinsic value calculation for ICL stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.6% for Israel Chemicals Shs.

Corporate tax rate of 27% is the nominal tax rate for Israel Chemicals Shs. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the ICL stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for ICL are equal to 88.9%.

Life of production assets of 13.1 years is the average useful life of capital assets used in Israel Chemicals Shs operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for ICL is equal to 21.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $3781 million for Israel Chemicals Shs - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 1280.961 million for Israel Chemicals Shs is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Israel Chemicals Shs at the current share price and the inputted number of shares is $6.8 billion.

RELATED COMPANIES Price Int.Val. Rating
MOS Mosaic Company 28.64 5.63  str.sell
ALB Albemarle Corp 86.43 101.19  hold
IPHS Innophos Holdi 30.78 30.25  hold

CONTACT US       ASSET ALLOCATION

About X-FIN       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2019. All rigths reserved.